[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338396-105":59,"doc-detail-338396-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","shenqifuzheng-injection-inhibits-lactic-acid-induced-cisplatin-resistance-in-nsclc-by-affecting-fbxo22p53-axis-through-foxo3-research-article-summary","Shenqifuzheng injection inhibits lactic acid-induced cisplatin resistance in NSCLC by affecting FBXO22/p53 axis through FOXO3 - Research Article Summary","","Non-small cell lung cancer (NSCLC) is highly prevalent, and cisplatin (DDP)-based chemotherapy is limited by DDP resistance, leading to poor long-term survival. This study evaluates whether Shenqifuzheng injection (SQFZ) mitigates lactic acid (LA)-driven DDP resistance and clarifies the underlying molecular mechanism. FOXO3, FBXO22 and p53 were measured in NSCLC tissues and cells, and functional assays assessed proliferation, apoptosis, lactate levels, and tumor growth.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/shenqifuzheng-injection-inhibits-lactic-acid-induced-cisplatin-resistance-in-nsclc-by-affecting-fbxo22p53-axis-through-foxo3-research-article-summary/338396/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/shenqifuzheng-injection-inhibits-lactic-acid-induced-cisplatin-resistance-in-nsclc-by-affecting-fbxo22p53-axis-through-foxo3-research-article-summary/338396.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in NSCLC?","Question",{"text":112,"@type":113},"The study focuses on DDP resistance in NSCLC and how it limits long-term survival, especially when resistance develops during chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were FOXO3, FBXO22, and p53 examined in the study?",{"text":117,"@type":113},"FOXO3, FBXO22, and p53 levels in NSCLC tissues and cells were assessed using RT-qPCR and Western blot.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathway links SQFZ to cisplatin resistance?",{"text":121,"@type":113},"SQFZ inhibits LA-induced DDP resistance through the FOXO3/FBXO22/p53 axis, where FOXO3 regulates FBXO22 and FBXO22 affects p53 ubiquitination.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338396,1790671620,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Bo etal. Respiratory Research (2024) 25:396 [https://doi.org/10.1186/s12931-024-03013-8](https://doi.org/10.1186/s12931-024-03013-8)  \nRespiratory Research  \nRESEARCH Open Access  \nShenqifuzheng injection inhibits lactic  acid-induced cisplatin resistance in NSCLC by affecting FBXO22/p53 axis through FOXO3  \nWei Bo 1,2, Xiaokai Wang2, Ning Yu 1, Chun Wang 1* and Chunying Liu 1*  \nAbstract  \nBackground Non-small cell lung cancer (NSCLC) accounts for 80% of lung cancers. Cisplatin (DDP)-based combination chemotherapy is the main treatment of NSCLC. Due to resistance to DDP, 5-year overall survival rate of NSCLC patients is very low. Shenqifuzheng injection (SQFZ) is essential for lung cancer progression. However, whether SQFZ plays a role in DDP resistance in NSCLC and its molecular mechanism remains unclear.  \nMethods Levels of FOXO3, FBXO22 and p53 in NSCLC tissues and cells were assessed by RT-qPCR and Western blot. Cell proliferation and apoptosis were analyzed utilizing CCK-8, Colony formation and Flow cytometry assays. Lactate (LA) levels were tested via ELISA. ChIP and Dual luciferase reporter assays validated regulatory relationship between FOXO3 and FBXO22 . Immunoprecipitation assay evaluated p53 ubiquitination levels. The subcutaneous tumor model of nude mice was constructed. TUNEL staining detected apoptosis in tissues, and IHC assessed expression of Ki67, FOXO3, FBXO22 and p53 .  \nResults FOXO3 was decreased, whereas LA and FBXO22 were increased in NSCLC patients. LA led to a higher DDP resistance in A549/DDP cells, while SQFZ reversed this effect by upregulating FOXO3 . Furthermore, FBXO22 was a downstream effecter of FOXO3 and FBXO22 affected p53 ubiquitination to reverse the inhibitory effect of SQFZ. We next found SQFZ inhibited LA-induced DDP resistance in NSCLC via FOXO3/FBXO22/p53 axis. Finally, SQFZ regulated LA-mediated DDP resistance in NSCLC nude mice.  \nConclusion SQFZ influences LA-induced DDP resistance in NSCLC via FOXO3/FBXO22/p53 pathway, providing a promising agent for NSCLC treatment.  \nHighlights  \n• FOXO3 was decreased, while LA and FBXO22 were increased in NSCLC patients.  \n• LA promoted cisplatin resistance in NSCLC in vitro and in vivo.  \n• SQFZ inhibited LA-induced cisplatin resistance in NSCLC by regulating FOXO3 .  \n• FBXO22 affected p53 ubiquitination to reverse the inhibitory effect of SQFZ.  \n• SQFZ inhibited cisplatin resistance in NSCLC by FOXO3/FBXO22/p53 axis.  \n*Correspondence:  \nChun Wang [1205055348@qq.com](1205055348@qq.com)[ ](1205055348@qq.com)Chunying Liu [liuchunying6288@163.com](liuchunying6288@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nBo et al. Respiratory Research (2024) 25:396 Page 2 of 15  \nKeywords Cisplatin resistance, FBXO22, FOXO3, Non-small cell lung cancer, p53, Shenqifuzheng injection  \nIntroduction  \nNon-small cell lung cancer (NSCLC) accounts for about 80% o","cbCait14G1BTB9I7","https://ap.wps.com/l/cbCait14G1BTB9I7","pdf",13844775,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Highlights\n# Introduction\n## Cisplatin resistance in NSCLC\n## Role of lactic acid in tumor microenvironment\n## Shenqifuzheng injection in cancer therapy","[{\"question\":\"What problem does the study address in NSCLC?\",\"answer\":\"The study focuses on DDP resistance in NSCLC and how it limits long-term survival, especially when resistance develops during chemotherapy.\"},{\"question\":\"How were FOXO3, FBXO22, and p53 examined in the study?\",\"answer\":\"FOXO3, FBXO22, and p53 levels in NSCLC tissues and cells were assessed using RT-qPCR and Western blot.\"},{\"question\":\"What molecular pathway links SQFZ to cisplatin resistance?\",\"answer\":\"SQFZ inhibits LA-induced DDP resistance through the FOXO3/FBXO22/p53 axis, where FOXO3 regulates FBXO22 and FBXO22 affects p53 ubiquitination.\"}]","Shenqifuzheng injection inhibits lactic acid-induced cisplatin resistance in NSCLC by affecting FBXO22/p53 axis through FOXO3 - Research Article Summary | PDF",1790023469,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/629459b599b5b8c0e330745a03be25f0.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d8d44fdcab5a2180cce899d4d997f3c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0146b63993e92a356ef663269d9bd9e8.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffffd09edc706b859c04a85aaa737dc1.webp",980,1306]